Beneficial effect of donepezil on obstructive sleep apnea: A double-blind, placebo-controlled clinical trial

Sleep Medicine

Volumn 13, Issue 3, 2012, Pages 290-296

  Sukys Claudino, Lucia ^a   Moraes, Walter ^a   Guilleminault, Christian ^b   Tufik, Sergio ^a   Poyares, Dalva ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetyl cholinesterase; Cholinergic; Donepezil; Obstructive sleep apnea; Oxygen desaturation; Polysomnography; Sleepiness; Treatment

Indexed keywords

DONEPEZIL; OXYGEN; PLACEBO;

ABNORMAL DREAMING; ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BEDTIME DOSAGE; BODY MASS; CHOLINERGIC TRANSMISSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; EPWORTH SLEEPINESS SCALE; HEADACHE; HUMAN; MALE; MOOD DISORDER; NAUSEA; NIGHTMARE; OXYGEN SATURATION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATION CONTROL; SALIVATION; SCORING SYSTEM; SIDE EFFECT; SINGLE DRUG DOSE; SLEEP APNEA SYNDROME; SLEEP QUALITY; SOMNOLENCE; TABLET FORMULATION; VIVID DREAM;

ADULT; AGED; CHOLINESTERASE INHIBITORS; DOUBLE-BLIND METHOD; HUMANS; INDANS; MALE; MIDDLE AGED; OXYGEN; PIPERIDINES; PLACEBOS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SLEEP STAGES; TREATMENT OUTCOME;

EID: 84857236727     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2011.09.014     Document Type: Article

References (38)

1. Bellingham M.C., Ireland M.F. Contribution of cholinergic systems to state-dependent modulation of respiratory control. Respir Physiol Neurobiol 2002, 131(1-2):135-144.
2. Kubin L., Fenik V. Pontine cholinergic mechanisms and their impact on respiratory regulation. Respir Physiol Neurobiol 2004, 143(2-3):235-249.
3. Benarroch E.E. Brainstem respiratory control: substrates of respiratory failure of multiple system atrophy. Mov Disord 2007, 22(2):155-161.
4. Smith C.A., Nakayama H., Dempsey J.A. The essential role of carotid body chemoreceptors in sleep apnea. Can J Physiol Pharmacol 2003, 81(8):774-779.
5. Shirahata M., Balbir A., Otsubo T., Fitzgerald R.S. Role of acetylcholine in neurotransmission of the carotid body. Respir Physiol Neurobiol 2007, 157(1):93-105.
6. Jones B. Basic mechanisms of sleep-wake states. Principles and practice of sleep medicine 2005, 136-153. Elsevier, Philadelphia.
7. Moraes W., Poyares D., Sukys-Claudino L., Guilleminault C., Tufik S. Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. Chest 2008, 133(3):677-683.
8. Blesa R., Garcia Ribas G., Galdos L., et al. Observational study on safety, tolerability and effectiveness of galantamine in patients with mild to moderately severe Alzheimer's disease. Neurologia 2006, 21(6):289-296.
9. Doody R.S., Corey-Bloom J., Zhang R., Li H., Ieni J., Schindler R. Safety and tolerability of donepezil at doses up to 20mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs Aging 2008, 25(2):163-174.
10. Moraes W., Poyares D.R., Guilleminault C., Ramos L.R., Bertolucci P.H., Tufik S. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. Sleep 2006, 29(2):199-205.
11. Cooke J.R., Loredo J.S., Liu L., et al. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs Aging 2006, 23(6):503-511.
12. Gilman S., Chervin R.D., Koeppe R.A., et al. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology 2003, 61(1):35-39.
13. Cormican L.J., Higgins S., Davidson A.C., Howard R., Williams A.J. Multiple system atrophy presenting as central sleep apnoea. Eur Respir J 2004, 24(2):323-325.
14. Hedner J., Kraiczi H., Peker Y., Murphy P. Reduction of sleep-disordered breathing after physostigmine. Am J Respir Crit Care Med 2003, 168(10):1246-1251.
15. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22(5):667-89.
16. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and a scoring system for sleep states of human subjects. Government Printing Office 1968.
17. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15(2):173-84.
18. Johns M.W. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994, 17(8):703-710.
19. Kasa P., Papp H., Kasa P., Torok I. Donepezil dose-dependently inhibits acetylcholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience 2000, 101(1):89-100.
20. Haxhiu M.A., Cherniack N.S., Mitra J., van Lunteren E., Strohl K.P. Nonvagal modulation of hypoglossal neural activity. Respiration 1992, 59(2):65-71.
21. Hedner E., Birkhed D., Hedner J., Ekstrom J., Helander H.F. Stimulation of minor salivary glands by intraoral treatment with the cholinesterase inhibitor physostigmine in man. Eur J Oral Sci 2001, 109(6):371-374.
22. Jokic R., Klimaszewski A., Mink J., Fitzpatrick M.F. Surface tension forces in sleep apnea: the role of a soft tissue lubricant: a randomized double-blind, placebo-controlled trial. Am J Respir Crit Care Med 1998, 157(5 Pt 1):1522-1525.
23. Malhotra A., Jordan A. Surface tension and sleep apnea: a sticky business. Sleep 2005, 28(4):392-393.
24. Shao X.M., Feldman J.L. Central cholinergic regulation of respiration: nicotinic receptors. Acta Pharmacol Sin 2009, 30(6):761-770.
25. Eckert D.J., Malhotra A. Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008, 5(2):144-153.
26. Jones B.E. Basic mechanisms of sleep-wake states. Principles and practice of sleep medicine 2005, 136-153. Elsevier, Philadelphia. 4th ed. M.H. Kryger, T. Roth, W.C. Dement (Eds.).
27. Jones B.E. The sleep-wake-cycle: basic mechanisms. J Rheumatol Suppl 1989, 19:49-51.
28. Slatkin N.E., Rhiner M. Treatment of opiate-related sedation: utility of the cholinesterase inhibitors. J Support Oncol 2003, 1(1):53-63.
29. Niederhofer H. Donepezil in the treatment of narcolepsy. J Clin Sleep Med 2006, 2(1):71-72.
30. Joseph V., Pequignot J.M., Van Reeth O. Neurochemical perspectives on the control of breathing during sleep. Respir Physiol Neurobiol 2002, 130(3):253-263.
31. Haxhiu M.A., Mack S.O., Wilson C.G., Feng P., Strohl K.P. Sleep networks and the anatomic and physiologic connections with respiratory control. Front Biosci 2003, 8:d946-d962.
32. Benarroch E.E., Schmeichel A.M., Parisi J.E. Depletion of cholinergic neurons of the medullary arcuate nucleus in multiple system atrophy. Auton Neurosci 2001, 87(2-3):293-299.
33. Benarroch E.E. Brainstem in multiple system atrophy: clinicopathological correlations. Cell Mol Neurobiol 2003, 23(4-5):519-526.
34. Benarroch E.E. New findings on the neuropathology of multiple system atrophy. Auton Neurosci 2002, 96(1):59-62.
35. Bliwise D.L. Sleep apnea, APOE4 and Alzheimer's disease 20years and counting?. J Psychosom Res 2002, 53(1):539-546.
36. Kadotani H., Kadotani T., Young T., et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 2001, 285(22):2888-2890.
37. Hedner J., Grote L., Zou D. Pharmacological treatment of sleep apnea: current situation and future strategies. Sleep Med Rev 2008, 12(1):33-47.
38. Smith I., Lasserson T.J., Wright J. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006, (2):CD003002.